Published in PLoS One on March 31, 2017
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Immunochemistry on ultrathin frozen sections. Histochem J (1980) 8.61
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
The equilibrative nucleoside transporter family, SLC29. Pflugers Arch (2003) 3.00
The burden of human African trypanosomiasis. PLoS Negl Trop Dis (2008) 2.53
Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem (1998) 2.05
Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A (2005) 2.03
Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2. J Biol Chem (2004) 1.76
The human brain endothelial cell line hCMEC/D3 as a human blood-brain barrier model for drug transport studies. J Neurochem (2008) 1.66
Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med (2004) 1.57
Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett (1997) 1.50
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res (2009) 1.46
Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab (2009) 1.35
Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect (2001) 1.33
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1. J Med Chem (2008) 1.32
Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob Agents Chemother (2002) 1.21
Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci (2000) 1.18
Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. J Antimicrob Chemother (2013) 1.18
Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major. Mol Biochem Parasitol (2003) 1.17
Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur J Pharm Sci (2008) 1.16
Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol (2001) 1.15
Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family. J Biol Chem (2006) 1.10
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling. J Med Chem (2013) 1.10
The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis. Am J Trop Med Hyg (1996) 1.10
Modulation of Leishmania ABC protein gene expression through life stages and among drug-resistant parasites. Eukaryot Cell (2006) 1.09
Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein. J Pharmacol Exp Ther (2009) 1.09
Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue. Acta Trop (2004) 1.08
Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. Acta Trop (2001) 1.08
Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J Physiol (2006) 1.07
The human concentrative and equilibrative nucleoside transporter families, SLC28 and SLC29. Mol Aspects Med (2013) 1.06
Aquaporin 2 mutations in Trypanosoma brucei gambiense field isolates correlate with decreased susceptibility to pentamidine and melarsoprol. PLoS Negl Trop Dis (2013) 1.04
Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions. PLoS One (2014) 1.03
Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1. Mol Pharmacol (2004) 1.02
Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters. Drug Metab Dispos (2008) 1.01
Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes (1982) 0.99
Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2. J Cereb Blood Flow Metab (2001) 0.96
Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J Neurochem (2005) 0.93
Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy. Mol Interv (2010) 0.92
Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol (2011) 0.91
Profiling solute carrier transporters in the human blood-brain barrier. Clin Pharmacol Ther (2013) 0.89
Transport of biogenic amine neurotransmitters at the mouse blood-retina and blood-brain barriers by uptake1 and uptake2. J Cereb Blood Flow Metab (2012) 0.88
Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins. Clin Exp Nephrol (2011) 0.84
Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein. Mol Microbiol (2015) 0.84
Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling. Cell Death Dis (2014) 0.83
Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors. Drug Metab Dispos (2015) 0.82
Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab Dispos (2012) 0.82
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: evidence for involvement of breast cancer resistance protein. Brain Res (2011) 0.82
Pentamidine-induced diabetes mellitus. Trans R Soc Trop Med Hyg (1984) 0.82
Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients. Pediatr Transplant (2015) 0.81
Trypanosoma brucei: maintenance of concentrated suspensions of bloodstream trypomastigotes in vitro using continuous dialysis for measurement of endocytosis. Exp Parasitol (1980) 0.80
Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins. J Neurochem (2015) 0.77
Haloperidol is an inhibitor but not substrate for MDR1/P-glycoprotein. J Pharm Pharmacol (2006) 0.77
The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J (2014) 0.77
Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters. Drug Metab Dispos (2006) 0.76
Evidence for an asymmetrical uptake of L-carnitine in the blood-brain barrier in vitro. Biochem Biophys Res Commun (1997) 0.76